A comparison of the skin permeation of three topical 0.5% Fluorouracil formulations with that of a 5% formulation

Clinical Therapeutics

Volumn 23, Issue 6, 2001, Pages 901-907

  Levy, Sharon ^a   Furst, Katharine ^a   Chern, Wendy ^a  

^a Dermik Laboratories   (United States)

Author keywords

Fluorouracil; Keratosis; Permeability; Pharmacokinetics; Skin absorption; Topical administration

Indexed keywords

FLUOROURACIL; MICROSPHERE;

ACTINIC KERATOSIS; ARTICLE; CADAVER; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; FULL THICKNESS SKIN GRAFT; HUMAN; HUMAN TISSUE; SKIN ABSORPTION; SKIN PERMEABILITY;

EID: 0034988533     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80077-1     Document Type: Article

References (22)

1. Skin changes in patients treated with 5-fluorouracil
2. Selective cytotoxic effect of topical 5-fluorouracil
3. Further studies with topical 5-fluorouracil
4. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses
5. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses
6. Noninflammatory destruction of actinic keratoses by fluorouracil
7. Topical 5-fluorouracil solution in the treatment of warts - clinical experience and percutaneous absorption
8. 14C-5-fluorouracil ointment applicated in an ointment to healthy and diseased human skin
9. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil
10. Clinical pharmacology of 5-fluorouracil
11. Topical delivery system for tretinoin: Research and clinical implications
12. 1) depends on the topical delivery system
13. Design and evaluation of a new transdermal formulation containing chlorpheniramine maleate
14. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability
15. Influence of formulation on the in vitro transdermal penetration of flutrimazole
16. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres
17. Current progress and future prospects of liposomes in dermal drug delivery
18. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy
19. The Microsponge delivery system (MDS): A topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives
20. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell
21. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis
22. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile